COMMUNIQUÉS West-GlobeNewswire

BioAro launches AI-Driven PanOmiQ with Ultrafast Whole Genome Sequencing Analysis Technology

03/02/2025 - 15:47

Transforming Genomic Medicine with Unprecedented Speed, Accuracy, and Accessibility - PanOmiQ Sets a New Standard with Analysis Time from VCF Files Under 5 Minutes, and Less Than 2 hrs for FASTQ Files CALGARY, Alberta, [...]

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer

03/02/2025 - 16:00

- Dr. Doebele has over 15 years of oncology drug development experience as a public company Chief Medical Officer and clinical researcher at leading cancer centers - SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- [...]

Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes

03/02/2025 - 16:00

Healthcare professionals are invited to register for the livestream option as a courtesy here Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the inaugural Smith+Nephew UFC Combat [...]

Foundation for Sarcoidosis Research (FSR) Announces $300,000 in Grant Funding to Improve Diagnosis and Treatment of Sarcoidosis

03/02/2025 - 17:30

CHICAGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) has awarded three pilot grants in the amount of $100,000 each, to Dr. Satish Sati from the University of Pennsylvania, Dr. Claire [...]

Navy confirms CLJA claim for 400k VSO members claiming erred discharge status

03/02/2025 - 17:35

ARLINGTON, Va., Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Department of the Navy has confirmed a petition filing from the Veteran Recovery Network (VRN) for over 400,000 eligible military veterans seeking CLJA Settlement [...]

Medigene AG announces closing of its first SEPA tranche

03/02/2025 - 18:00

Planegg/Martinsried, February 3, 2025. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies [...]

Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025

03/02/2025 - 18:24

Travel Health business demonstrated strong growth of 22%. Additional mpox vaccine orders during outbreak drove higher revenues for the Public Preparedness business and also secured a strong foundation for 2025. [...]

Already Autism Health Announces Acquisition of CABS Autism Services

03/02/2025 - 18:32

CHARLOTTE, N.C., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Already Autism Health has announced the acquisition of C.A.B.S., Autism and Behavior Specialists (CABS). Founded in 2008 by Amanda Parker, BCBA, CABS has built a strong [...]

Transparency Notifications from Shareholders

03/02/2025 - 20:45

Transparency Notifications from Shareholders Ghent, Belgium – 3 February 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of fluid overload in [...]

Gyder Surgical Announces 510(k) FDA clearance for the GYDER® Hip System, the World’s First Commercially Available Pin-less and Image-less Solution for Accurate Positioning of the Acetabular Cup during Anterior Hip Arthroplasty

03/02/2025 - 21:04

MULGRAVE, Australia & PALO ALTO, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Gyder Surgical, a MedTech company specializing in intuitive, orthopaedic navigation solutions, today announced the 510(k) FDA clearance for [...]

GH Research Announces Proposed Public Offering

03/02/2025 - 22:03

DUBLIN, Feb. 03, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in [...]

Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

03/02/2025 - 22:05

CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer [...]

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

03/02/2025 - 22:05

ST. LOUIS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial [...]

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

03/02/2025 - 22:05

MOUNTAIN VIEW, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that an abstract [...]

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

03/02/2025 - 22:05

FOSTER CITY, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

03/02/2025 - 22:05

DENVER, Feb. 03, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced the closing of its previously announced registered direct offering, priced at-the-market [...]

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/02/2025 - 22:05

BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, [...]

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

03/02/2025 - 22:09

SANTA CLARA, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the fourth [...]

Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request

03/02/2025 - 22:10

Ji’an, Jiangxi, China, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a letter [...]